Computed tomography–based image-guided brachytherapy for cervical cancer: correlations between dose–volume parameters and clinical outcomes
Authors:
Open Access
- 23 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 59 (1) , 67-76
Abstract
This study evaluated the oncologic outcomes and complications of cervical cancer patients in terms of CT-based image-guided brachytherapy (IGBT) parameters. Of 68 cervical cancer patients treated with definitive radiotherapy/concurrent chemoradiotherapy, most received whole-pelvis external beam RT (EBRT) of 40 Gy in 20 fractions, pelvic EBRT with central shield of 10 Gy in 5 fractions, and CT-based IGBT of 18 Gy in 3 fractions prescribed to point A. Cumulative EBRT and IGBT doses were calculated as the total equivalent dose in 2 Gy fractions (EQD2). The median follow-up was 31 (3–52) months. The 2-year overall survival, local control, pelvic control, and disease-free survival rates of the 68 patients were 92%, 83%, 82% and 73%, respectively. The HR-CTV D90, length from the tandem axis to left/right margin of the HR-CTV (T-LR), and HR-CTV volume were significant IGBT parameters for predicting local/pelvic control. Patients who received an HR-CTV D90 of >60 Gy, compared with ≤60 Gy, had significantly better local/pelvic control. Furthermore, 70 Gy was a marginally significant HR-CTV D90 cut-off affecting local control. T-LR was an independent IGBT parameter predicting local/pelvic control on multivariate analysis. Three patients developed Grade 3 or higher treatment-related complications. The D2cm3 of organs at risk were not significant predictors of complications. Future challenges for further improving outcomes include additional interstitial needles for irregularly shaped HR-CTVs, and moderate dose escalation, especially for patients with poor tumor responses.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology of Japan (16K10398)
This publication has 25 references indexed in Scilit:
- Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy SocietyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Image-Based Brachytherapy for the Treatment of Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancerInternational Journal of Clinical Oncology, 2015
- Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Dose Effect Relationship for Late Side Effects of the Rectum and Urinary Bladder in Magnetic Resonance Image-Guided Adaptive Cervix Cancer BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapyBrachytherapy, 2012
- Dose–Volume Histogram Parameters and Late Side Effects in Magnetic Resonance Image–Guided Adaptive Cervical Cancer BrachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Computed Tomography Versus Magnetic Resonance Imaging-Based Contouring in Cervical Cancer Brachytherapy: Results of a Prospective Trial and Preliminary Guidelines for Standardized ContoursInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Long‐term results of high‐dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervixCancer, 2004